In a patient with neurogenic bladder who performs intermittent self‑catheterisation and has a urine culture growing >100 000 CFU/mL Enterococcus faecalis, should antimicrobial therapy be initiated?

Do Not Treat This Asymptomatic Bacteriuria

In a patient with neurogenic bladder performing intermittent self-catheterization who has >100,000 CFU/mL Enterococcus faecalis on urine culture, you should NOT initiate antimicrobial therapy if the patient is asymptomatic. This is asymptomatic bacteriuria (ASB), and treatment provides no clinical benefit while promoting antimicrobial resistance and adverse drug events 1.

The Critical Distinction: Symptoms vs. Bacteria

The presence of bacteria alone—even at high colony counts—does not constitute a urinary tract infection requiring treatment in neurogenic bladder patients. Multiple high-quality guidelines uniformly recommend against treating ASB in this population:

• The 2024 EAU Guidelines explicitly state: "Do not treat catheter-associated asymptomatic bacteriuria in general" (Strong recommendation) 1
• The 2021 AUA/SUFU Guidelines confirm: "Clinicians should not treat asymptomatic bacteriuria in patients with NLUTD" (Moderate recommendation) 2
• The 2019 IDSA Guidelines reinforce: "Asymptomatic bacteriuria should not be screened for or treated in spinal cord–injured patients" (A-II recommendation) 3

When Symptoms Actually Matter

You should only treat if the patient has true symptoms of UTI, which in neurogenic bladder patients include:

• Systemic signs: Fever, rigors, hemodynamic instability
• New or worsening urinary symptoms: Increased spasticity, autonomic dysreflexia, suprapubic pain, malodorous/cloudy urine WITH systemic symptoms
• Upper tract involvement: Flank pain, costovertebral angle tenderness

Common pitfall: Cloudy urine, odor, and pyuria alone are NOT indications for treatment in catheterized patients—these findings are ubiquitous in neurogenic bladder and do not predict symptomatic infection 4.

Why Not Treating Is the Right Decision

The evidence strongly supports withholding antibiotics:

1. No clinical benefit: Randomized trials in intermittent catheterization patients show similar rates of symptomatic UTI whether ASB is treated or not (0.92 vs 0.67 cases per patient-year, p=NS) 3

2. Harm from treatment: Antibiotic therapy leads to:

   • Significantly more adverse drug events
   • Reinfection with more resistant organisms
   • Development of multidrug-resistant bacteria 3

3. High recurrence: Bacteriuria recurs rapidly after treatment—78% of weekly cultures remain positive despite treatment, with only 10% achieving organism eradication 5

4. Resistance concerns: In neurogenic bladder populations, 55-87% of isolates are already multidrug-resistant, and unnecessary treatment accelerates this problem 5

The Two Exceptions to This Rule

You should treat ASB in only two specific scenarios:

1. Before traumatic urologic procedures (e.g., transurethral resection, urodynamics with anticipated mucosal trauma) to prevent bacteremia and sepsis 1, 3

2. Pregnancy (though this scenario is less relevant to your specific question) 2

Practical Management Algorithm

If asymptomatic with positive culture:

• Do NOT prescribe antibiotics
• Optimize catheterization technique (frequency, hydration)
• Continue routine surveillance per risk stratification
• Educate patient that bacteria are expected and not harmful

If symptomatic (fever, systemic signs, new symptoms):

• Send urine culture before starting antibiotics
• Start empiric therapy based on local resistance patterns
• Adjust to culture-directed therapy when available
• Treat for 7-14 days depending on severity 4

Additional Considerations for Enterococcus faecalis

While E. faecalis is a common colonizer in catheterized patients and can act as a "pioneer species" facilitating biofilm formation 6, this microbiologic finding alone does not warrant treatment in the absence of symptoms. The organism's presence at >100,000 CFU/mL simply confirms colonization, which is expected in up to 50-69% of patients performing intermittent catheterization 7.

The bottom line: Resist the reflex to treat a positive culture. In neurogenic bladder patients on intermittent self-catheterization, bacteriuria is colonization, not infection, and treatment causes more harm than benefit through resistance development and adverse effects without improving clinical outcomes 1, 2, 3.